0.569
前日終値:
$0.569
開ける:
$0.5757
24時間の取引高:
16,494
Relative Volume:
0.04
時価総額:
$19.27M
収益:
-
当期純損益:
$-98.79M
株価収益率:
-0.174
EPS:
-3.27
ネットキャッシュフロー:
$-51.66M
1週間 パフォーマンス:
-11.11%
1か月 パフォーマンス:
-9.68%
6か月 パフォーマンス:
+66.37%
1年 パフォーマンス:
-82.44%
Relmada Therapeutics Inc Stock (RLMD) Company Profile
名前
Relmada Therapeutics Inc
セクター
電話
646 876 3459
住所
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, NY
RLMD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
3.03 | 0 | 0 | 0 | 0 | 0.00 | |
![]()
MOBBW
Mobilicom Limited Warrants
|
0.72 | 835.81M | 0 | 0 | 0 | 0.00 |
![]()
GOODO
Gladstone Commercial Corporation
|
20.52 | 372.90M | 0 | 0 | 0 | 0.00 |
![]()
SHMD
Schmid Group N V
|
2.65 | 121.87M | 0 | 0 | 0 | 0.00 |
![]()
PSNYW
Polestar Automotive Holding Uk
|
0.1546 | 313.13M | 2.07B | -1.42B | -1.37B | -0.6765 |
![]()
DAVEW
Dave Inc
|
1.35 | 0 | 0 | 0 | 0 | 0.00 |
Relmada Therapeutics Inc Stock (RLMD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-05 | ダウングレード | Mizuho | Outperform → Neutral |
2024-09-17 | アップグレード | Jefferies | Hold → Buy |
2024-06-05 | ダウングレード | Goldman | Neutral → Sell |
2022-10-14 | ダウングレード | Goldman | Buy → Neutral |
2022-10-14 | ダウングレード | Guggenheim | Buy → Neutral |
2022-10-14 | ダウングレード | Truist | Buy → Hold |
2022-10-13 | ダウングレード | Oppenheimer | Outperform → Perform |
2021-11-18 | 開始されました | Mizuho | Buy |
2021-05-20 | 再開されました | Goldman | Buy |
2020-10-28 | ダウングレード | Goldman | Buy → Neutral |
2020-07-14 | 開始されました | Oppenheimer | Outperform |
2020-05-04 | 開始されました | SunTrust | Buy |
2020-04-21 | 開始されました | Goldman | Buy |
2020-01-27 | 開始されました | Jefferies | Buy |
2020-01-10 | 開始されました | SVB Leerink | Outperform |
2019-12-16 | 開始されました | Guggenheim | Buy |
すべてを表示
Relmada Therapeutics Inc (RLMD) 最新ニュース
Advanced analytics toolkit walkthrough for Relmada Therapeutics Inc.Real Time Alert System for Market Moves - Newser
Is a relief rally coming for Relmada Therapeutics Inc. holdersSafe Entry Zone Based on Chart Analysis - Newser
Using fundamentals and technicals on Relmada Therapeutics Inc.Reversal Signal Prediction Based on Volume - Newser
What makes Relmada Therapeutics Inc. stock price move sharplyROI Focused Setup Screener With Exit Markers - Newser
How to monitor Relmada Therapeutics Inc. with trend dashboardsSmart Swing Picks with Confirmed Signals - Newser
What’s next for Relmada Therapeutics Inc. stock priceFree Early Entry Tips With Low Risk Zone - Newser
Published on: 2025-08-04 12:29:06 - metal.it
Will a bounce in Relmada Therapeutics Inc. offer an exitWeekly Setup Summary for Risk Controlled Trades - Newser
What are the latest earnings results for Relmada Therapeutics Inc.Get alerts on top growth stocks daily - Jammu Links News
Why Relmada Therapeutics Inc. stock attracts strong analyst attentionFree Alert Feed for Momentum Based Picks - Newser
Using portfolio simulators with Relmada Therapeutics Inc. includedShort-Term Stock Trend Forecast Guide - Newser
What catalysts could drive Relmada Therapeutics Inc. stock higher in 2025Unlock powerful trading signals for profits - Jammu Links News
How volatile is Relmada Therapeutics Inc. stock compared to the marketRobust investment performance - Jammu Links News
How does Relmada Therapeutics Inc. compare to its industry peersBuild a diversified portfolio for steady growth - Jammu Links News
What institutional investors are buying Relmada Therapeutics Inc. stockInvest in stocks with strong fundamentals - Jammu Links News
What analysts say about Relmada Therapeutics Inc. stockInvest in stocks with long-term growth potential - Jammu Links News
What drives Relmada Therapeutics Inc. stock priceCapitalize on emerging market opportunities - Jammu Links News
Real time breakdown of Relmada Therapeutics Inc. stock performanceOversold Reversal Picks with Buy Zone - Newser
What is the risk reward ratio of investing in Relmada Therapeutics Inc. stockAccess daily stock market expert updates - Jammu Links News
What are analysts’ price targets for Relmada Therapeutics Inc. in the next 12 monthsUnbelievable profit margins - Jammu Links News
How strong is Relmada Therapeutics Inc. company’s balance sheetInvest in stocks with strong fundamentals - Jammu Links News
Why is Relmada Therapeutics Inc. stock attracting strong analyst attentionStay informed with daily expert analysis - Jammu Links News
What are Relmada Therapeutics Inc. company’s key revenue driversStay informed with daily expert analysis - Jammu Links News
Relmada Therapeutics (RLMD.US) will release its earnings reports after the market closes on August 7th. - 富途牛牛
Building trade automation scripts for Relmada Therapeutics Inc.Free Safe Entry Stock Watch Suggestions - Newser
Relmada Therapeutics to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - The Manila Times
Relmada Therapeutics Sets Q2 Earnings Date: Key Updates Expected on Oncology and CNS Pipeline - Stock Titan
Relmada Therapeutics Inc. At Decision Level — Rebound or ResistanceReal Time Stock Movement Analysis Indicates Breakout - beatles.ru
Relmada Therapeutics (NASDAQ:RLMD) Shares Down 2.3% – Here’s What Happened - Defense World
Does Relmada Therapeutics Inc. stock perform well during market downturnsBeginner Investor Growth Plan For Every Investor - Jammu Links News
When is Relmada Therapeutics Inc. stock expected to show significant growthPost Market Outlook For Every Investor - Jammu Links News
Why Relmada Therapeutics Inc. stock attracts strong analyst attention Monthly Trade Result and Signal Summary - Newser
Why Relmada Therapeutics Inc. stock attracts strong analyst attention AI Screener Based Stock Summary Report - metal.it
Relmada Therapeutics Inc (RLMD) 財務データ
収益
当期純利益
現金流量
EPS
Relmada Therapeutics Inc (RLMD) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Shenouda Maged | Chief Financial Officer |
May 19 '25 |
Buy |
0.49 |
90,000 |
43,686 |
228,335 |
Shenouda Maged | Chief Financial Officer |
May 20 '25 |
Buy |
0.52 |
60,000 |
31,422 |
288,335 |
Shenouda Maged | Chief Financial Officer |
May 16 '25 |
Buy |
0.44 |
50,000 |
22,100 |
138,335 |
Ence Chuck | CA and CO |
May 16 '25 |
Buy |
0.45 |
228,961 |
103,330 |
267,931 |
TRAVERSA SERGIO | Chief Executive Officer |
May 20 '25 |
Buy |
0.56 |
147,686 |
82,246 |
734,024 |
TRAVERSA SERGIO | Chief Executive Officer |
May 16 '25 |
Buy |
0.45 |
172,314 |
77,472 |
556,338 |
TRAVERSA SERGIO | Chief Executive Officer |
May 19 '25 |
Buy |
0.50 |
30,000 |
14,994 |
586,338 |
TRAVERSA SERGIO | Chief Executive Officer |
Sep 11 '24 |
Buy |
2.99 |
51,407 |
153,707 |
384,024 |
TRAVERSA SERGIO | Chief Executive Officer |
Sep 09 '24 |
Buy |
2.71 |
55,579 |
150,619 |
299,603 |
TRAVERSA SERGIO | Chief Executive Officer |
Sep 10 '24 |
Buy |
2.75 |
33,014 |
90,788 |
332,617 |
大文字化:
|
ボリューム (24 時間):